{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": true,
    "leverage": true,
    "inverse": true,
    "complex_factors": [
        "3x Leverage",
        "Inverse Exposure",
        "Synthetic Replication via Funded Swap",
        "Counterparty Risk",
        "Daily Reset and Compounding Effect",
        "High Risk Level (7/7)",
        "Collateralised Swap Structure"
    ],
    "classification": "complex",
    "supporting_data": "The product is a Collateralised Exchange Traded Product (ETP) that seeks to replicate -3 times the daily performance of MicroStrategy Inc via the Solactive Daily Leveraged 3x Short MicroStrategy Index. It uses a funded swap agreement with Natixis as the Swap Provider, with collateral held in a segregated account. The replication method is synthetic, relying on derivative instruments (swaps) to achieve leveraged inverse exposure. The product explicitly states a 3x leverage factor with daily reset, causing compounding effects that can significantly deviate returns over periods longer than one day. The risk indicator is at the highest level (7/7), indicating very high risk and complexity. The product is not UCITS compliant and carries significant counterparty risk, as the ability to pay depends on the Swap Provider and collateral arrangements. The product is intended for investors with specific knowledge and experience, highlighting its complexity. There is no capital protection, and the product may lose the entire investment. These factors combined\u2014synthetic replication, leverage, inverse exposure, swap usage, and high risk\u2014drive the classification as complex under MiFID II."
}